Seeing Is Believing

Currently out of the existing stock ratings of Glen Santangelo, 108 are a BUY (67.92%), 49 are a HOLD (30.82%), 2 are a SELL (1.26%).
Analyst Glen Santangelo, currently employed at JEFFERIES, carries an average stock price target met ratio of 59.14% that have a potential upside of 23.76% achieved within 200 days.
Glen Santangelo’s has documented 328 price targets and ratings displayed on 41 stocks. The coverage is on Healthcare, Consumer Defensive, Technology sectors.
Most recent stock forecast was given on ALGN, Align Technology at 10-Oct-2025.
Analyst best performing recommendations are on TRHC (TABULA RASA HEALTHCARE).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) at 10/7/2019. The price target of $200 was fulfilled within 4 days with a profit of $15.49 (8.4%) receiving and performance score of 20.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$215
$40.04 (22.89%)
$187
2 years 2 months 28 days ago
(07-Aug-2023)
13/14 (92.86%)
$28.91 (15.54%)
633
Hold
$190
$15.04 (8.60%)
$176
2 years 3 months 1 days ago
(03-Aug-2023)
8/8 (100%)
$-0.86 (-0.45%)
433
Buy
$220
$45.04 (25.74%)
$213
2 years 3 months 1 days ago
(03-Aug-2023)
11/17 (64.71%)
$29.14 (15.27%)
326
Buy
$215
$40.04 (22.89%)
$200
2 years 3 months 1 days ago
(03-Aug-2023)
6/8 (75%)
$24.14 (12.65%)
220
Buy
$225
$50.04 (28.60%)
$184
2 years 3 months 3 days ago
(01-Aug-2023)
11/12 (91.67%)
$36.39 (19.29%)
557
Which stock is Glen Santangelo is most bullish on?
Which stock is Glen Santangelo is most reserved on?
What Year was the first public recommendation made by Glen Santangelo?